David Lukton

Array ( [id] => 8834700 [patent_doc_number] => 08450456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it' [patent_app_type] => utility [patent_app_number] => 12/808266 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6862 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12808266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5491037 [patent_doc_number] => 20090292108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Insulinotropic peptide synthesis using solid and solution phase combination techniques' [patent_app_type] => utility [patent_app_number] => 12/316309 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44732 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20090292108.pdf [firstpage_image] =>[orig_patent_app_number] => 12316309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286216 [patent_doc_number] => 08642545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/747818 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 11596 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322847 [patent_doc_number] => 20090060837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'COBALAMIN CONJUGATES USEFUL AS ANTITUMOR AGENTS' [patent_app_type] => utility [patent_app_number] => 12/266763 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060837.pdf [firstpage_image] =>[orig_patent_app_number] => 12266763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265480 [patent_doc_number] => 20090118165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'METHOD OF TREATING CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA' [patent_app_type] => utility [patent_app_number] => 12/266244 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10070 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118165.pdf [firstpage_image] =>[orig_patent_app_number] => 12266244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453188 [patent_doc_number] => 20090069225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'SOMATOSTATIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/265135 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8484 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069225.pdf [firstpage_image] =>[orig_patent_app_number] => 12265135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501608 [patent_doc_number] => 20090162296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Approach to treat intraocular hypertension' [patent_app_type] => utility [patent_app_number] => 12/289388 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12454 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162296.pdf [firstpage_image] =>[orig_patent_app_number] => 12289388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422927 [patent_doc_number] => 20090149382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Modulation of lipid rafts' [patent_app_type] => utility [patent_app_number] => 12/289390 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14454 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149382.pdf [firstpage_image] =>[orig_patent_app_number] => 12289390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446954 [patent_doc_number] => 20090048180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Sustained-release preparation' [patent_app_type] => utility [patent_app_number] => 12/285494 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15441 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048180.pdf [firstpage_image] =>[orig_patent_app_number] => 12285494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4442292 [patent_doc_number] => 07928069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Crosslinked compounds and methods of making and using thereof' [patent_app_type] => utility [patent_app_number] => 12/244135 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 21697 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928069.pdf [firstpage_image] =>[orig_patent_app_number] => 12244135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576124 [patent_doc_number] => 20090143486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'CHARGE REVERSIBLE POLYMERS' [patent_app_type] => utility [patent_app_number] => 12/242191 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6840 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143486.pdf [firstpage_image] =>[orig_patent_app_number] => 12242191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576203 [patent_doc_number] => 20090143565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Methods for the Synthesis of Two or More Dicarba Bridges in Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/239164 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 54487 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143565.pdf [firstpage_image] =>[orig_patent_app_number] => 12239164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626739 [patent_doc_number] => 08796418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Stabilized alpha helical peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/233555 [patent_app_country] => US [patent_app_date] => 2008-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 83 [patent_no_of_words] => 18735 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12233555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423192 [patent_doc_number] => 20090149648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'NUCLEOTIDE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/211745 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 68701 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149648.pdf [firstpage_image] =>[orig_patent_app_number] => 12211745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296106 [patent_doc_number] => 20100240587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'STABLE FORMULATIONS OF AMYLIN AND ITS ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/676970 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8871 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240587.pdf [firstpage_image] =>[orig_patent_app_number] => 12676970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453177 [patent_doc_number] => 20090069214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Modulator of Metabolism Processes and Method of Its Receiving' [patent_app_type] => utility [patent_app_number] => 12/208607 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9194 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069214.pdf [firstpage_image] =>[orig_patent_app_number] => 12208607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506877 [patent_doc_number] => 20100210556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677583 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34550 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210556.pdf [firstpage_image] =>[orig_patent_app_number] => 12677583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10019624 [patent_doc_number] => 09062095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies' [patent_app_type] => utility [patent_app_number] => 12/733347 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 35441 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177614 [patent_doc_number] => 08178650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Cyclic depsipeptides' [patent_app_type] => utility [patent_app_number] => 12/193338 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28352 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178650.pdf [firstpage_image] =>[orig_patent_app_number] => 12193338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082345 [patent_doc_number] => 08148492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Synthetic pulmonary surfactant peptides' [patent_app_type] => utility [patent_app_number] => 12/222517 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4983 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148492.pdf [firstpage_image] =>[orig_patent_app_number] => 12222517 [rel_patent_id] =>[rel_patent_doc_number] =>)